Is it safe to combine BPC-157 and TB-500 for recovery?

BPC-157 and TB-500 are frequently combined in research due to their complementary mechanisms, with BPC-157 focusing on localized tissue repair and TB-500 supporting systemic healing and cell migration. Preclinical studies report minimal adverse effects, though long-term human safety data is lacking. Important considerations include never mixing these peptides in the same vial as it may compromise stability, and avoiding concurrent NSAID use which may counteract healing effects. Neither peptide is FDA-approved, and medical supervision is recommended for anyone considering this combination.